Jim Cramer runs the charitable trust portfolio, Action Alerts PLUS, and writes daily market commentary for TheStreet's RealMoney premium service. He also participates in video segments on TheStreet TV and serves as host of CNBC's "Mad Money" television program.
Cramer graduated magna cum laude from Harvard College, where he was president of The Harvard Crimson. He worked as a journalist at the Tallahassee Democrat and the Los Angeles Herald Examiner, covering everything from sports to homicide before moving to New York to help start American Lawyer magazine. After a three-year stint, Cramer entered Harvard Law School and received his J.D. in 1984. Instead of practicing law, however, he joined Goldman Sachs, where he worked in sales and trading. In 1987, he left Goldman to start his own hedge fund. While he worked at his fund, Cramer helped start Smart Money for Dow Jones and then, in 1996, he founded TheStreet. In 2000, Cramer retired from active money management to embrace media full time, including radio and television.
Cramer is the author of Confessions of a Street Addict," "You Got Screwed," "Jim Cramer's Real Money," "Jim Cramer's Mad Money," "Jim Cramer's Stay Mad for Life," "Jim Cramer's Getting Back to Even" and, most recently,"Get Rich Carefully." He has written for Time magazine and New York magazine and has been featured on CBS' 60 Minutes, NBC's Nightly News with Brian Williams, Meet the Press, Today, The Tonight Show, Late Night and MSNBC's Morning Joe
Recent Articles By The Author
Activism Makes a Comeback; French Elections: Jim Cramer's Best Blog
Jim Cramer ponders how to play the French elections and discusses how activism is making a comeback.
Cramer: How to Play The French Elections
Good reports from three stocks offer a way to play the French election angst.
Here Is What Jim Cramer Expects From Alcoa's Earnings
TheStreet's Jim Cramer is keeping an eye on quarterly results from Alcoa AA released on Monday.
Here Is What Jim Cramer Expects From Halliburton's Earnings
TheStreet's Jim Cramer is keeping an eye on quarterly results from Halliburton, released on Monday.
Jim Cramer on Valeant Pharmaceuticals: The Debt Is Humongous
TheStreet's Jim Cramer said Valeant Pharmaceuticals' debt load is humongous.